Correlation Between Knight Therapeutics and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Knight Therapeutics and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Canntab Therapeutics.
Diversification Opportunities for Knight Therapeutics and Canntab Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Knight and Canntab is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between Knight Therapeutics and Canntab Therapeutics
If you would invest 0.01 in Canntab Therapeutics Limited on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Canntab Therapeutics Limited or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Knight Therapeutics vs. Canntab Therapeutics Limited
Performance |
| Timeline |
| Knight Therapeutics |
| Canntab Therapeutics |
Knight Therapeutics and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Knight Therapeutics and Canntab Therapeutics
The main advantage of trading using opposite Knight Therapeutics and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.| Knight Therapeutics vs. Rezolute | Knight Therapeutics vs. Tempest Therapeutics | Knight Therapeutics vs. Forte Biosciences | Knight Therapeutics vs. Dyadic International |
| Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |